tradmap

ORMP ORAMED PHARMACEUTICALS INC.

$4.94 -2.37%

Updated

Healthcare · Pharmaceutical Preparations

ORAMED PHARMACEUTICALS INC. (ORMP) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $205 million. Shares last traded at $4.94, 9.7% below their 52-week high. Over the past year the stock is up 128.7%. ORMP trades at a price-to-earnings ratio of 1.18, below the Pharmaceutical Preparations median of 17.31. Revenue grew 49.3% year over year.

Market Cap
$205M
Shares Out
41.6M
EPS (TTM)
$5.06
P/E Ratio
0.98
P/S Ratio
102.75
P/B Ratio
0.65
Dividend / Share
Dividend Yield
52-Week High
$5.47
52-Week Low
$2.09
Volume
8,075
Avg Vol (3m)
13,808.778

Performance

1W
-2.76%
1M
+14.09%
3M
+28.98%
6M
+44.87%
YTD
+69.47%
1Y
+128.70%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
57.60
SMA (50)
$4.46
SMA (200)
$3.73
Price vs SMA50
+10.72%
Price vs SMA200
+32.56%
ATR (14)
$0.23

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2M
Net Income
$175M
Gross Margin
0.7%
Operating Margin
-726.2%
Net Margin
Return on Equity
55.1%
Return on Assets
47.3%
Current Ratio
4.98
Debt / Equity
0.23
Revenue Growth (YoY)
+49.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $2.76 2026-08-10
Q1 2026 $0.91 2026-05-19
FY 2025 $1.50 2026-03-26
Q3 2025 $1.26 2025-11-13
Q2 2026 $0.13 2026-08-10
Q1 2026 $-0.19 2026-05-19

Full earnings history →

Pharmaceutical Preparations peers

ORMP vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/E vs peers
1.18 / 17.31 med
-93% discount
P/S vs peers
102.75 / 11.11 med
+825% premium
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.